| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Net sales | ||||||
1,835,900 | 1,961,000 | 1,878,600 | 1,770,100 | 2,542,300 | 843,200 | |
Cost of sales | ||||||
1,047,600 | 1,123,400 | 1,064,800 | 992,800 | 1,550,400 | 446,600 | |
Gross profit | ||||||
788,300 | 837,600 | 813,800 | 777,300 | 991,900 | 396,600 | |
Operating expenses: | ||||||
Selling, technical, general and administrative | ||||||
497,000 | 544,800 | 567,200 | 596,300 | 857,500 | 360,900 | |
Research and development | ||||||
42,200 | 44,300 | 46,400 | 45,000 | 62,800 | 26,200 | |
Goodwill impairment | ||||||
- | - | - | 46,600 | 0 | 0 | |
Total operating expenses | ||||||
539,200 | 589,100 | 613,600 | 687,900 | 920,300 | 387,100 | |
Operating profit | ||||||
249,100 | 248,500 | 200,200 | 89,400 | 71,600 | 9,500 | |
(Loss) gain on derivative contracts | ||||||
- | - | - | - | - | 400 | |
Foreign exchange loss | ||||||
- | - | - | - | -43,400 | -2,700 | |
Other (expense) income: | ||||||
Interest expense, net | ||||||
-90,700 | -311,000 | -336,900 | -372,300 | -213,900 | -37,900 | |
Foreign exchange (loss) gain | ||||||
28,700 | -5,500 | -53,700 | -34,500 | - | - | |
Other income (expense), net | ||||||
-46,200 | 14,800 | -70,000 | 85,600 | -43,600 | -200 | |
Total other expense | ||||||
-108,200 | -301,700 | -460,600 | -321,200 | -300,900 | -40,400 | |
Income (loss) before income taxes and non-controlling interests | ||||||
140,900 | -53,200 | -260,400 | -231,800 | -229,300 | -30,900 | |
Income tax (expense) benefit | ||||||
61,300 | 23,800 | -68,600 | -41,300 | 75,100 | -6,700 | |
Net income (loss) from continuing operations | ||||||
79,600 | -77,000 | -191,800 | -190,500 | - | - | |
Income from discontinued operations, net of tax | ||||||
13,300 | -242,900 | -103,800 | 113,800 | - | - | |
Net income | ||||||
92,900 | -319,900 | -295,600 | -76,700 | -304,400 | -24,200 | |
Net income attributable to non-controlling interests | ||||||
700 | 4,500 | 600 | -3,000 | 4,200 | 5,700 | |
Net loss attributable to stockholders | ||||||
- | - | - | -73,700 | -308,600 | -29,900 | |
Stock dividend on Founder's preferred shares | ||||||
- | - | - | - | - | 232,700 | |
Gain on amendment of Series B Convertible Preferred Stock | ||||||
- | - | - | 32,900 | 0 | 0 | |
Net income attributable to common stockholders | ||||||
92,200 | -324,400 | -296,200 | -40,800 | -308,600 | -262,600 | |
Earnings (loss) per share | ||||||
Basic from continuing operations (in dollars per share) | ||||||
0.31 | -0.27 | -0.68 | -0.62 | - | - | |
Basic from discontinued operations (in dollars per share) | ||||||
0.05 | -0.86 | -0.36 | 0.45 | - | - | |
Basic (in dollars per share) | ||||||
0.36 | -1.13 | -1.04 | -0.17 | -1.52 | -1.94 | |
Diluted from continuing operations (in dollars per share) | ||||||
0.30 | -0.27 | -0.68 | -1.06 | - | - | |
Diluted from discontinued operations (in dollars per share) | ||||||
0.05 | -0.86 | -0.36 | 0.41 | - | - | |
Diluted (in dollars per share) | ||||||
0.35 | -1.13 | -1.04 | -0.65 | -1.52 | -1.94 | |
Weighted average common shares outstanding | ||||||
Basic (in shares) | ||||||
257,600 | 288,200 | 286,100 | 243,300 | 203,200 | 135,300 | |
Diluted (in shares) | ||||||
260,100 | 288,200 | 286,100 | 272,300 | 203,200 | 135,300 | |